The latest from CDMOs, CMOs, and suppliers featuring Yposkesi and LTS Lohmann Therapie-Systeme.  

Biologics Manufacturing 
* Yposkesi Launches Lentiviral Vector Mfg Platform
Formulation Development/Drug Product Manufacturing 
* LTS Acquires Wearable Injection Device Platform 

---

Biologics Manufacturing 

Yposkesi Launches Lentiviral Vector Mfg Platform 
Yposkesi, an Evry-Courcouronnes, France-based CDMO of cell and gene therapies and part of SK pharmteco, has launched LentiSure, a lentiviral vector manufacturing platform optimized for higher yields and production efficiencies. Lentiviral vectors are used to produce cell-based immuno-oncology therapies. 

Source: Yposkesi 

---

Formulation Development/Drug Product Manufacturing 

LTS Acquires Wearable Injection Device Business 
LTS Lohmann Therapie-Systeme, an Andernach, Germany-based provider of drug-delivery technology and systems, has acquired the Sorrel wearable injection device platform from Eitan Medical, a Netanya, Israel-based provider of advanced infusion therapies and drug-delivery systems. Sorrel is a digitally integrated platform for subcutaneous delivery of injectable drugs and biologics.   

Source: LTS Lohmann Therapie-Systeme